Tempest Therapeutics, Inc. Common Stock (TPST) Stock Price

TPSTStock

$1.11−89.03%52W

Market Cap$18.36M

P/E—

PEG Ratio—

Div yield—

Beta-1.73

TPST Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-64.83%

Price vs S&P 500 (4W)23.24%

VGM Score23.88

Book Value / Share (Quarterly)$0.06

P/TBV (Annual)4.17x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-1.84

Price vs S&P 500 (YTD)-73.63%

Gross Margin (TTM)-46.67%

Net Profit Margin (TTM)-9760.00%

EPS (TTM)$-6.21

10-Day Avg Trading Volume0.46M

EPS Excl Extra (TTM)$-6.21

EPS (Annual)$-6.33

ROI (Annual)-393.85%

Gross Margin (Annual)-166.67%

Cash / Share (Quarterly)$0.13

Revenue Growth QoQ (YoY)0.00%

ROA (Last FY)-155.11%

Revenue Growth TTM (YoY)-6.25%

EBITD / Share (TTM)$-7.16

ROE (5Y Avg)-199.70%

Operating Margin (TTM)-10020.00%

Cash Flow / Share (Annual)$-5.44

P/B Ratio22.94x

P/B Ratio (Quarterly)28.62x

Net Income / Employee (Annual)$-6,565,500

EV / Revenue (TTM)56.84x

Net Interest Coverage (TTM)-87.30x

ROA (TTM)-248.79%

EPS Incl Extra (Annual)$-6.33

Current Ratio (Annual)2.50x

Quick Ratio (Quarterly)0.55x

3-Month Avg Trading Volume0.20M

52-Week Price Return-89.03%

Revenue / Employee (TTM)$75,000

Tangible BV / Share (Quarterly)$-0.08

P/S Ratio (Annual)62.85x

Asset Turnover (Annual)0.00x

52-Week High$12.23

EPS Excl Extra (Annual)$-6.33

CapEx CAGR (5Y)1.69%

Tangible BV CAGR (5Y)-22.38%

26-Week Price Return-53.59%

Quick Ratio (Annual)2.43x

13-Week Price Return-39.23%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)0.74x

Enterprise Value$17.05M

Asset Turnover (TTM)0.01x

Book Value / Share Growth (5Y)-44.36%

Revenue / Employee (Annual)$75,000

Pretax Margin (Annual)-16970.00%

Cash / Share (Annual)$1.56

3-Month Return Std Dev78.91%

Net Income / Employee (TTM)$-10,774,500

ROE (Last FY)-393.85%

Net Interest Coverage (Annual)-2110.20x

EPS Basic Excl Extra (Annual)$-6.33

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-6.21

ROI (TTM)-729.89%

P/S Ratio (TTM)62.85x

Revenue / Share (Annual)$1.88

Tangible BV / Share (Annual)$1.72

Price vs S&P 500 (52W)-107.34%

Year-to-Date Return-61.67%

5-Day Price Return2.80%

EPS Normalized (Annual)$-6.33

ROA (5Y Avg)-85.85%

Net Profit Margin (Annual)-16993.33%

Month-to-Date Return28.46%

Cash Flow / Share (TTM)$-2.20

EBITD / Share (Annual)$-6.34

Operating Margin (Annual)-16870.00%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-163.53%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-6.21

P/B Ratio (Annual)2.12x

Pretax Margin (TTM)-9746.67%

Book Value / Share (Annual)$1.35

Price vs S&P 500 (13W)-42.02%

Beta-1.73x

Revenue / Share (TTM)$1.88

ROE (TTM)-729.89%

52-Week Low$0.84

vGradeF

gGradeD

mGradeF

vgmGradeD

TPST Earnings Surprise History

Q2 25-2.07est. -3.23

Q3 25-0.79est. -3.27

Q4 25-0.62est. -0.62

Q1 26-0.50est. -0.28

TPST Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.14

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
TPSTTempest Therapeutics, Inc. Common Stock	F	D	F	$1.11
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Tempest Therapeutics, Inc. Common Stock

Tempest Therapeutics is a late-stage biotechnology company developing small molecule cancer therapeutics designed to directly eliminate tumor cells while activating anti-tumor immunity. The company's clinical-stage pipeline includes TPST-1120 and TPST-1495, targeting distinct mechanisms in oncology.